Latest News and Press Releases
Want to stay updated on the latest news?
-
– The IMPROVE-HCM Phase 2 clinical trial met the primary endpoint of safety and tolerability; 12-weeks treatment with ninerafaxstat also demonstrated a statistically significant improvement, compared...
-
CHADDS FORD, PA--(Marketwire - March 1, 2010) - The Society of Plastics Engineers (SPE) has named Associated Packaging Technologies (APT), the Chadds Ford, PA-based maker of CPET and...